Why Translational Medicine Will Never be The Same

There have been 2 or 3 courses in my entire education that have changed
the way I think.  This is one of those
.
Hobart Harris Professor and Chief, Division of General Surgery at UCSF

For the past three years the National Science Foundation Innovation Corps has been teaching our nations best scientists how to build a Lean Startup.  Close to 400 teams in robotics, computer science, materials science, geoscience, etc. have learned how to use business models, get out of the building to test their hypotheses and minimum viable product.

However, business models in the Life Sciences are a bit more complicated than those in software, web/mobile or hardware. Startups in the Life Sciences (therapeutics, diagnostics, devices, digital health, etc.) also have to understand the complexities of reimbursement, regulation, intellectual property and clinical trials.

Last fall we prototyped an I-Corps class for life sciences at UCSF with 25 teams. Hobart Harris led one of the teams.

What Hobart learned and how he learned it is why we’re about to launch the I-Corps @ NIH on Oct 6th.

If you can’t see the video click here

Translational medicine will never be the same.

6 Responses

  1. All you life science folks need 2 look at this

    Brian Darmody
    Associate Vice President for Corporate and Foundation Relations
    4113 Riggs Alumni Center
    University of Maryland
    College Park, Maryland 20742

    bdarmody@umd.edu
    301 928 0527 (cell)
    301 405 1990

    Sent from my iPhone

    • Thanks, Steve.

      Wave of the Future is already here. Now.

      Was sitting at a retreat at Strawberry Ranch, Half Moon Bay, in 1999, when Peter Schwartz [Global Business Network futurist] predicted so much of this stuff.

      At the time, everyone was focused on other stuff, and listened politely,
      but did not really hear what Peter was saying. They were more focused on Y2K [which mostly fizzled out].

      So many of Peter’s forecasts are coming true. Amazing.

      lee moldaver, ALE
      santa barbara

    • Brian,
      I agree. Not just science folks, but engineers, teachers, investors, govt administrators and legislators controlling funding need to look at this and understand the basics of business development that every entrepreneur figures out through the results in his bank acct whether to continue down a path, pivot or hang it up.
      It begs the question why does it cost $75 million in regulatory compliance to get an idea that can help people get to market? How much did the polio vaccine cost to develop? Any course that can help mitigate the waste, fraud and abuse in higher ed, science and health care when public or private money is at stake being spent on developing projects that have limited need for development is a good thing.

  2. The Pivot is the key. Here’s a guy smart enough to not believe that he’s smart enough to muscle through. Great reminder for me. If I think I’m the smartest guy in the room, I need to get OUT OF THE BUILDING!

  3. This is great feedback. How do we get more medtech, biotech & healthtech entrepreneurs connected with these methods?

    • Carol,
      Much more to come on this subject.
      We’re in the midst of running a pilot at our National Institutes of Health as we speak.

      steve

Leave a Reply

Discover more from Steve Blank

Subscribe now to keep reading and get access to the full archive.

Continue reading